National Institute of Siddha
🇮🇳India
- Country
- 🇮🇳India
- Ownership
- Private
- Established
- 2005-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.nischennai.org
Clinical Trials
687
Active:8
Completed:265
Trial Phases
5 Phases
Phase 1:24
Phase 2:285
Phase 3:151
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (583 trials with phase data)• Click on a phase to view related trials
Phase 2
285 (48.9%)Phase 3
151 (25.9%)Not Applicable
106 (18.2%)Phase 1
24 (4.1%)phase_2_3
9 (1.5%)phase_1_2
6 (1.0%)Phase 4
2 (0.3%)Evaluation of Preclinical Toxicity andTherapeutic Efficacy of Kandhaga Rasayanam in Padarthamarai
Phase 2
Completed
- Conditions
- Tinea Infections Such as Tinea Corporis, Tinea Cruris, Tinea Pedis, Tinea Mannum, Tinea Barbae, Tinea Capitis Are Studied
- Interventions
- Drug: kandhaga rasayanam
- First Posted Date
- 2014-09-12
- Last Posted Date
- 2014-09-12
- Lead Sponsor
- National institute of Siddha
- Target Recruit Count
- 50
- Registration Number
- NCT02238912
- Locations
- 🇮🇳
National institute of siddha, Chennai, Tamilnadu, India
News
No news found